IXHL: Incannex Healthcare Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Incannex Healthcare Inc (IXHL).
$46.67M Market Cap.
IXHL Market Cap. (MRY)
IXHL Shares Outstanding (MRY)
IXHL Assets (MRY)
Total Assets
$17.05M
Total Liabilities
$5.83M
Total Investments
$0
IXHL Income (MRY)
Revenue
$12.00K
Net Income
-$18.46M
Operating Expense
$30.05M
IXHL Cash Flow (MRY)
CF Operations
-$15.85M
CF Investing
-$277.00K
CF Financing
$0
IXHL Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total Assets | $17,047,000 (-28.32%) | $23,783,000 (-37.21%) | $37,879,608 (306.05%) | $9,328,795 (120.22%) |
Assets Current | $16,202,000 (-29.55%) | $22,997,000 (-39.29%) | $37,879,608 (306.05%) | $9,328,795 (120.22%) |
Assets Non-Current | $845,000 (7.51%) | $786,000 (0%) | $0 (0%) | $0 (0%) |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Shareholders Equity | $11,217,000 (-46.14%) | $20,825,000 (-38.49%) | $33,858,542 (333.05%) | $7,818,697 (124.04%) |
Property Plant & Equipment Net | $845,000 (7.51%) | $786,000 (0%) | $0 (0%) | $0 (0%) |
Cash & Equivalents | $5,858,000 (-73.52%) | $22,120,000 (-41.01%) | $37,500,931 (311.03%) | $9,123,617 (153.20%) |
Accumulated Other Comprehensive Income | -$3,332,000 (-2.37%) | -$3,255,000 (0%) | $0 (0%) | $0 (0%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $0 (0%) | $0 (0%) | $294,717 (74.30%) | $169,088 (-59.09%) |
Trade & Non-Trade Payables | $612,000 (-64.99%) | $1,748,000 (-13.06%) | $2,010,533 (166.28%) | $755,049 (-20.94%) |
Accumulated Retained Earnings (Deficit) | -$110,671,000 (-20.02%) | -$92,212,000 (-56.84%) | -$58,794,910 (-33.96%) | -$43,891,002 (-34.97%) |
Tax Assets | $9,837,000 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $373,000 (-28.41%) | $521,000 (0%) | $0 (0%) | $0 (0%) |
Debt Current | $163,000 (44.25%) | $113,000 (0%) | $0 (0%) | $0 (0%) |
Debt Non-Current | $210,000 (-48.53%) | $408,000 (0%) | $0 (0%) | $0 (0%) |
Total Liabilities | $5,830,000 (97.09%) | $2,958,000 (47.13%) | $2,010,533 (166.28%) | $755,049 (-29.54%) |
Liabilities Current | $5,620,000 (120.39%) | $2,550,000 (26.83%) | $2,010,533 (166.28%) | $755,049 (-29.54%) |
Liabilities Non-Current | $210,000 (-48.53%) | $408,000 (0%) | $0 (0%) | $0 (0%) |
IXHL Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Revenues | $12,000 (0%) | $0 (0%) | $0 (0%) | $1,973,344 (140.05%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $6,338 (-99.31%) | $911,969 (102.50%) |
Selling General & Administrative Expense | $17,174,000 (114.35%) | $8,012,000 (-8.07%) | $8,715,228 (23.02%) | $7,084,617 (336.00%) |
Research & Development Expense | $12,879,000 (104.14%) | $6,309,000 (17.45%) | $5,371,821 (13.10%) | $4,749,514 (125.03%) |
Operating Expenses | $30,053,000 (-39.49%) | $49,668,000 (216.63%) | $15,686,225 (26.15%) | $12,434,174 (189.10%) |
Interest Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Income Tax Expense | $30,000 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$18,459,000 (62.18%) | -$48,811,000 (-227.50%) | -$14,903,909 (-31.05%) | -$11,372,799 (-142.10%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$18,459,000 (62.18%) | -$48,811,000 (-227.50%) | -$14,903,909 (-31.05%) | -$11,372,799 (-142.10%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$18,459,000 (62.18%) | -$48,811,000 (-227.50%) | -$14,903,909 (-31.05%) | -$11,372,799 (-142.10%) |
Weighted Average Shares | $16,164,338 (5.07%) | $15,384,704 (27.30%) | $12,085,280 (0.00%) | $12,085,280 (0.00%) |
Weighted Average Shares Diluted | $16,164,338 (5.07%) | $15,384,704 | - | - |
Earning Before Interest & Taxes (EBIT) | -$18,429,000 (62.24%) | -$48,811,000 (-227.50%) | -$14,903,909 (-31.05%) | -$11,372,799 (-142.10%) |
Gross Profit | $12,000 (0%) | $0 (0%) | -$6,338 (-100.60%) | $1,061,375 (185.54%) |
Operating Income | -$30,041,000 (39.52%) | -$49,668,000 (-216.51%) | -$15,692,563 (-37.98%) | -$11,372,799 (-189.44%) |
IXHL Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Net Cash Flow from Investing | -$277,000 (12.34%) | -$316,000 (0%) | $0 (0%) | $29,277 (125.21%) |
Net Cash Flow from Financing | $0 (0%) | $8,175,000 (-80.15%) | $41,184,687 (232.12%) | $12,400,730 (67.48%) |
Net Cash Flow from Operations | -$15,845,000 (-47.41%) | -$10,749,000 (16.07%) | -$12,807,373 (-85.35%) | -$6,909,780 (-76.84%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$16,122,000 (-457.85%) | -$2,890,000 (-110.18%) | $28,377,314 (414.06%) | $5,520,227 (57.27%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $29,277 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Capital Expenditure | -$277,000 (12.34%) | -$316,000 (0%) | $0 (0%) | $0 (0%) |
Issuance (Repayment) of Debt Securities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Issuance (Purchase) of Equity Shares | $0 (0%) | $8,175,000 (-80.15%) | $41,184,687 (232.12%) | $12,400,730 (66.02%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | -$140,000 (83.01%) | -$824,000 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $8,928,000 (315.45%) | $2,149,000 (0%) | $0 (0%) | $0 (0%) |
Depreciation Amortization & Accretion | $103,000 (17.05%) | $88,000 (0%) | $0 (0%) | $0 (0%) |
IXHL Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Gross Margin | 100.00% | - | - | 53.80% (19.03%) |
Profit Margin | -153825.00% | - | - | -576.30% (-0.84%) |
EBITDA Margin | -152716.70% | - | - | -576.30% (-0.84%) |
Return on Average Equity (ROAE) | -115.20% (35.46%) | -178.50% (-149.65%) | -71.50% (-177.63%) | 92.10% (232.49%) |
Return on Average Assets (ROAA) | -90.40% (42.89%) | -158.30% (-150.87%) | -63.10% (62.37%) | -167.70% (15.13%) |
Return on Sales (ROS) | -153575.00% | - | - | -576.30% (-0.84%) |
Return on Invested Capital (ROIC) | -661.00% (-113.53%) | 4886.30% (257.66%) | 1366.20% (-40.61%) | 2300.20% (128.63%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% | - |
Price to Earnings Ratio (P/E) | -2.56 (-15.65%) | -2.21 (82.08%) | -12.34 | - |
Price to Sales Ratio (P/S) | 3,960.29 | - | - | - |
Price to Book Ratio (P/B) | 4.16 (-25.63%) | 5.59 (1.64%) | 5.5 | - |
Debt to Equity Ratio (D/E) | 0.52 (266.20%) | 0.14 (140.68%) | 0.06 (-39.18%) | 0.1 (393.94%) |
Earnings Per Share (EPS) | -1.15 (65.36%) | -3.32 (-165.60%) | -1.25 (-7.76%) | -1.16 (-68.12%) |
Sales Per Share (SPS) | 0 (0%) | 0 (0%) | 0 (0%) | 0.16 (139.71%) |
Free Cash Flow Per Share (FCFPS) | -1 (-38.66%) | -0.72 (32.17%) | -1.06 (-85.31%) | -0.57 (-77.64%) |
Book Value Per Share (BVPS) | 0.69 (-48.74%) | 1.35 (-51.68%) | 2.8 (333.08%) | 0.65 (124.04%) |
Tangible Assets Book Value Per Share (TABVPS) | 1.05 (-31.76%) | 1.55 (-50.67%) | 3.13 (305.96%) | 0.77 (119.94%) |
Enterprise Value Over EBIT (EV/EBIT) | -2 (0.00%) | -2 (81.82%) | -11 | - |
Enterprise Value Over EBITDA (EV/EBITDA) | -2.06 (-33.40%) | -1.54 (86.18%) | -11.18 | - |
Asset Turnover | 0 (0%) | 0 (0%) | 0 (0%) | 0.29 (-15.90%) |
Current Ratio | 2.88 (-68.03%) | 9.02 (-52.14%) | 18.84 (52.50%) | 12.36 (212.55%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$16,122,000 (-45.70%) | -$11,065,000 (13.60%) | -$12,807,373 (-85.35%) | -$6,909,780 (-77.43%) |
Enterprise Value (EV) | $37,770,952 (-49.84%) | $75,294,804 (-54.80%) | $166,584,513 | - |
Earnings Before Tax (EBT) | -$18,429,000 (62.24%) | -$48,811,000 (-227.50%) | -$14,903,909 (-31.05%) | -$11,372,799 (-142.10%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$18,326,000 (62.39%) | -$48,723,000 (-226.91%) | -$14,903,909 (-31.05%) | -$11,372,799 (-142.10%) |
Invested Capital | $5,942,000 (1723.50%) | -$366,000 (77.57%) | -$1,631,856 (-196.77%) | -$549,871 (-25.27%) |
Working Capital | $10,582,000 (-48.25%) | $20,447,000 (-43.00%) | $35,869,075 (318.36%) | $8,573,746 (170.94%) |
Tangible Asset Value | $17,047,000 (-28.32%) | $23,783,000 (-37.21%) | $37,879,608 (306.05%) | $9,328,795 (120.22%) |
Market Capitalization | $46,666,952 (-59.94%) | $116,486,561 (-37.49%) | $186,355,018 | - |
Average Equity | $16,021,000 (-41.40%) | $27,341,771 (31.21%) | $20,838,620 (268.74%) | -$12,349,753 (27.08%) |
Average Assets | $20,415,000 (-33.78%) | $30,831,304 (30.62%) | $23,604,202 (248.02%) | $6,782,437 (185.34%) |
Invested Capital Average | $2,788,000 (379.10%) | -$998,928 (8.43%) | -$1,090,864 (-120.64%) | -$494,416 (-5.89%) |
Shares | 15,873,113 (0.02%) | 15,870,104 (31.32%) | 12,085,280 (0.00%) | 12,085,280 (0.00%) |